165 related articles for article (PubMed ID: 29129391)
1. Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery.
Timmermans M; Schuurman MS; Ho VKY; Massuger LF; Nijman HW; van Gorp T; Sonke GS; Kruitwagen RFPM; van der Aa MA
Gynecol Oncol; 2018 Jan; 148(1):56-61. PubMed ID: 29129391
[TBL] [Abstract][Full Text] [Related]
2. Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands.
Eggink FA; Mom CH; Kruitwagen RF; Reyners AK; Van Driel WJ; Massuger LF; Niemeijer GC; Van der Zee AG; Van der Aa MA; Nijman HW
Gynecol Oncol; 2016 Jun; 141(3):524-530. PubMed ID: 27090157
[TBL] [Abstract][Full Text] [Related]
3. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
Bristow RE; Palis BE; Chi DS; Cliby WA
Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study.
Said SA; van der Aa MA; Veldmate G; de Hullu JA; van Altena AM
Acta Obstet Gynecol Scand; 2022 Jan; 101(1):56-67. PubMed ID: 34719790
[TBL] [Abstract][Full Text] [Related]
5. Non-surgical management of ovarian cancer: Prevalence and implications.
Shalowitz DI; Epstein AJ; Ko EM; Giuntoli RL
Gynecol Oncol; 2016 Jul; 142(1):30-37. PubMed ID: 27107721
[TBL] [Abstract][Full Text] [Related]
6. Outcome of surgery in advanced ovarian cancer varies between geographical regions; opportunities for improvement in The Netherlands.
Timmermans M; Sonke GS; Slangen BFM; Baalbergen A; Bekkers RLM; Fons G; Gerestein CG; Kruse AJ; Roes EM; Zusterzeel PLM; Van de Vijver KK; Kruitwagen RFPM; van der Aa MA
Eur J Surg Oncol; 2019 Aug; 45(8):1425-1431. PubMed ID: 31027945
[TBL] [Abstract][Full Text] [Related]
7. Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands.
van Altena AM; Karim-Kos HE; de Vries E; Kruitwagen RF; Massuger LF; Kiemeney LA
Gynecol Oncol; 2012 Jun; 125(3):649-54. PubMed ID: 22370602
[TBL] [Abstract][Full Text] [Related]
8. Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.
Sinno AK; Li X; Thompson RE; Tanner EJ; Levinson KL; Stone RL; Temkin SM; Fader AN; Chi DS; Long Roche K
Gynecol Oncol; 2017 Jun; 145(3):493-499. PubMed ID: 28366546
[TBL] [Abstract][Full Text] [Related]
9. Centralisation of epithelial ovarian cancer surgery: results on survival from a peripheral teaching hospital.
van Vliet MM; Schreuder HW; Pasker-de Jong PC; Duk MJ
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():72-8. PubMed ID: 26177496
[TBL] [Abstract][Full Text] [Related]
10. Intestinal surgery in treatment of advanced ovarian cancer--review of our experience.
Stefanović A; Jeremić K; Kadija S; Milincić N; Mircić A; Petković S; Zizić V
Eur J Gynaecol Oncol; 2011; 32(4):419-22. PubMed ID: 21941966
[TBL] [Abstract][Full Text] [Related]
11. Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer.
Zwakman N; van de Laar R; Van Gorp T; Zusterzeel PL; Snijders MP; Ferreira I; Massuger LF; Kruitwagen RF
J Gynecol Oncol; 2017 Jan; 28(1):e7. PubMed ID: 27670261
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV.
Ataseven B; Grimm C; Harter P; Heitz F; Traut A; Prader S; du Bois A
Gynecol Oncol; 2016 Feb; 140(2):215-20. PubMed ID: 26691222
[TBL] [Abstract][Full Text] [Related]
13. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
14. No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands.
Timmermans M; Sonke GS; Van de Vijver KK; van der Aa MA; Kruitwagen RFPM
Eur J Cancer; 2018 Jan; 88():31-37. PubMed ID: 29179135
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer.
Hinchcliff E; Melamed A; Bregar A; Diver E; Clemmer J; Del Carmen M; Schorge JO; Alejandro Rauh-Hain J
Gynecol Oncol; 2018 Jan; 148(1):168-173. PubMed ID: 29128105
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.
Alessi A; Martinelli F; Padovano B; Serafini G; Lorusso D; Lorenzoni A; Ditto A; Lecce F; Mira M; Donfrancesco C; Raspagliesi F; Crippa F
Tumori; 2016; 102(1):103-7. PubMed ID: 26350201
[TBL] [Abstract][Full Text] [Related]
17. Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population.
Falconer H; Joneborg U; Krawiec K; Palsdottir K; Bottai M; Salehi S
Gynecol Oncol; 2020 Oct; 159(1):58-65. PubMed ID: 32712154
[TBL] [Abstract][Full Text] [Related]
18. Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer.
Kumar A; Janco JM; Mariani A; Bakkum-Gamez JN; Langstraat CL; Weaver AL; McGree ME; Cliby WA
Gynecol Oncol; 2016 Jan; 140(1):15-21. PubMed ID: 26541980
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
[TBL] [Abstract][Full Text] [Related]
20. Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma.
Fauci JM; Schneider KE; Frederick PJ; Wilding G; Consiglio J; Sutton AL; Kilgore LC; Barnes MN
Int J Gynecol Cancer; 2011 Jul; 21(5):806-10. PubMed ID: 21412162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]